Report Overview
Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Pregabalin market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Pregabalin market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Pregabalin market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Pregabalin products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Pregabalin products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Pregabalin market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Pregabalin development has been the leading industry trend of Pregabalin market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Pregabalin Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Epilepsy, Neuropathic Pain, Fibromyalgia, Generalized Anxiety Disorder |
| By Application Outlook |
Research Institutes, Pharmaceutical Companies, Others (Hospitals and Clinics) |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Pfizer Inc., Torrent Pharmaceuticals Ltd., Lupin Limited, Zydus Cadila Healthcare Ltd., Cipla Limited, Genesis Remedies, Sanofi, Medley Pharmaceuticals Limited, Genesis Biotec Inc., Biomax |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Pfizer Inc.
- Torrent Pharmaceuticals Ltd.
- Lupin Limited
- Zydus Cadila Healthcare Ltd.
- Cipla Limited
- Genesis Remedies
- Sanofi
- Medley Pharmaceuticals Limited
- Genesis Biotec Inc.
- Biomax
PREGABALIN Market, By Type
- Epilepsy
- Neuropathic Pain
- Fibromyalgia
- Generalized Anxiety Disorder
PREGABALINMarket, By Application
- Research Institutes
- Pharmaceutical Companies
- Others (Hospitals and Clinics)
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table Of Contents
Table of Contents
1 Pregabalin Market Overview
1.1 Pregabalin Product Overview
1.2 Pregabalin Market Segment by Type
1.2.1 Epilepsy
1.2.2 Neuropathic Pain
1.2.3 Fibromyalgia
1.2.4 Generalized Anxiety Disorder
1.3 Global Pregabalin Market Size by Type
1.3.1 Global Pregabalin Sales and Growth by Type
1.3.2 Global Pregabalin Sales and Market Share by Type (2013-2018)
1.3.3 Global Pregabalin Revenue and Market Share by Type (2013-2018)
1.3.4 Global Pregabalin Price by Type (2013-2018)
2 Global Pregabalin Market Competition by Company
2.1 Global Pregabalin Sales and Market Share by Company (2013-2018)
2.2 Global Pregabalin Revenue and Share by Company (2013-2018)
2.3 Global Pregabalin Price by Company (2013-2018)
2.4 Global Top Players Pregabalin Manufacturing Base Distribution, Sales Area, Product Types
2.5 Pregabalin Market Competitive Situation and Trends
2.5.1 Pregabalin Market Concentration Rate
2.5.2 Global Pregabalin Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Pregabalin Company Profiles and Sales Data
3.1 Pfizer Inc.
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Pregabalin Product Category, Application and Specification
3.1.3 Pfizer Inc. Pregabalin Sales, Revenue, Price and Gross Margin(2013-2018)
3.1.4 Main Business Overview
3.2 Torrent Pharmaceuticals Ltd.
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Pregabalin Product Category, Application and Specification
3.2.3 Torrent Pharmaceuticals Ltd. Pregabalin Sales, Revenue, Price and Gross Margin(2013-2018)
3.2.4 Main Business Overview
3.3 Lupin Limited
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Pregabalin Product Category, Application and Specification
3.3.3 Lupin Limited Pregabalin Sales, Revenue, Price and Gross Margin(2013-2018)
3.3.4 Main Business Overview
3.4 Zydus Cadila Healthcare Ltd.
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Pregabalin Product Category, Application and Specification
3.4.3 Zydus Cadila Healthcare Ltd. Pregabalin Sales, Revenue, Price and Gross Margin(2013-2018)
3.4.4 Main Business Overview
3.5 Cipla Limited
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Pregabalin Product Category, Application and Specification
3.5.3 Cipla Limited Pregabalin Sales, Revenue, Price and Gross Margin(2013-2018)
3.5.4 Main Business Overview
3.6 Genesis Remedies
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Pregabalin Product Category, Application and Specification
3.6.3 Genesis Remedies Pregabalin Sales, Revenue, Price and Gross Margin(2013-2018)
3.6.4 Main Business Overview
3.7 Sanofi
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Pregabalin Product Category, Application and Specification
3.7.3 Sanofi Pregabalin Sales, Revenue, Price and Gross Margin(2013-2018)
3.7.4 Main Business Overview
3.8 Medley Pharmaceuticals Limited
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Pregabalin Product Category, Application and Specification
3.8.3 Medley Pharmaceuticals Limited Pregabalin Sales, Revenue, Price and Gross Margin(2013-2018)
3.8.4 Main Business Overview
3.9 Genesis Biotec Inc.
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Pregabalin Product Category, Application and Specification
3.9.3 Genesis Biotec Inc. Pregabalin Sales, Revenue, Price and Gross Margin(2013-2018)
3.9.4 Main Business Overview
3.10 Biomax
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Pregabalin Product Category, Application and Specification
3.10.3 Biomax Pregabalin Sales, Revenue, Price and Gross Margin(2013-2018)
3.10.4 Main Business Overview
4 Pregabalin Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Pregabalin Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Pregabalin Sales and Revenue by Regions
4.2.1 Global Pregabalin Sales and Market Share by Regions (2013-2018)
4.2.2 Global Pregabalin Revenue and Market Share by Regions (2013-2018)
4.2.3 Global Pregabalin Sales, Revenue, Price and Gross Margin (2013-2018)
4.3 North America Pregabalin Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Pregabalin Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Pregabalin Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Pregabalin Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Pregabalin Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Pregabalin Application/End Users
5.1 Pregabalin Segment by Application
5.1.1 Research Institutes
5.1.2 Pharmaceutical Companies
5.1.3 Others (Hospitals and Clinics)
5.2 Global Pregabalin Product Segment by Application
5.2.1 Global Pregabalin Sales by Application
5.2.2 Global Pregabalin Sales and Market Share by Application (2013-2018)
6 Global Pregabalin Market Forecast
6.1 Global Pregabalin Sales, Revenue Forecast (2018-2025)
6.1.1 Global Pregabalin Sales and Growth Rate Forecast (2018-2025)
6.1.1 Global Pregabalin Revenue and Growth Rate Forecast (2018-2025)
6.2 Global Pregabalin Forecast by Regions
6.2.1 North America Pregabalin Sales and Revenue Forecast (2018-2025)
6.2.2 Europe Pregabalin Sales and Revenue Forecast (2018-2025)
6.2.3 Asia-Pacific Pregabalin Sales and Revenue Forecast (2018-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Pregabalin Sales and Revenue Forecast (2018-2025)
6.2.5 Middle East and Africa Pregabalin Sales and Revenue Forecast (2018-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Pregabalin Forecast by Type
6.3.1 Global Pregabalin Sales and Revenue Forecast by Type (2018-2025)
6.3.2 Epilepsy Gowth Forecast
6.3.3 Neuropathic Pain Gowth Forecast
6.4 Pregabalin Forecast by Application
6.4.1 Global Pregabalin Sales Forecast by Application (2018-2025)
6.4.2 Global Pregabalin Forecast in Research Institutes
6.4.3 Global Pregabalin Forecast in Pharmaceutical Companies
7 Pregabalin Upstream Raw Materials
7.1 Pregabalin Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Pregabalin Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer